Organisation paid for research Program year 2025 Source: CMS Open Payments

St Louis Univ

Neither a doctor nor a teaching hospital

Research payments

$277,012

317 payments

Through program year 2025, St Louis Univ is reported as receiving $277,012 in research payments, across 317 payments.

By program year

7 rows

Year	Kind	Amount	Payments
2025	Research	$28,815	2
2024	Research	$750	1
2023	Research	$1,280	2
2022	Research	$2,560	4
2021	Research	$3,655	3
2020	Research	$113,103	118
2019	Research	$126,849	187

Breakdown

Who paid Research payments · program years 2019–2025

Boehringer Ingelheim International GmbH $159,972 276 payments
Boehringer Ingelheim Pharma GmbH & Co.KG $48,796 17 payments
Janssen Research & Development, LLC $29,565 3 payments
Novo Nordisk AS $24,755 18 payments
Siemens Medical Solutions USA, Inc. $12,895 1 payment
Boehringer Ingelheim Pharmaceuticals, Inc. $1,030 2 payments

Studies the money was for Research payments · program years 2019–2025

Empagliflozin and Heart failure (HFrEF) $155,570 176 payments
Empagliflozin and heart failure (HFpEF) $53,197 117 payments
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (LIBREXIA-ACS) $28,815 2 payments
Nn9535-4416 $13,505 12 payments
SLU Vaheesan Radiology PAE AX $12,895 1 payment
Nn1250-4300 $10,800 5 payments
GLORIA AF Registry Phase II III Core $1,030 2 payments
70033093Acs3003 $750 1 payment
Nn9924-4338 $450 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.